top of page

Promethean1 transparent.png

HOME
ABOUT US
SERVICES
PRODUCTS
AUSTRALIA
FIND A DOCTOR
NEWS
- RESOURCES
- ANNOUNCEMENTS
CLINICAL RESOURCES
CONTACT
- INVESTORS
More

Use tab to navigate through the menu items.

Search

Oct 4, 2021

Therapeutic Goods Administration relaxes the requirements on nicotine as an unregistered medicine

Sep 18, 2021

Novel psychedelic medicines are the next global health revolution

Aug 10, 2021

Sale of TCann to Promethean

Jul 6, 2021

Promethean BioPharma supports the rescheduling of psilocybin and MDMA in Australia

Jan 7, 2021

The Third Promethean Moment

Announcements

NAVIGATION

HOME
ABOUT US
SERVICES
PRODUCTS
AUSTRALIA
FIND A DOCTOR
NEWS
- RESOURCES
- ANNOUNCEMENTS
CLINICAL RESOURCES
CONTACT
- INVESTORS

SERVICES WE OFFER

Medical Advisory

CONTACT US

contact@prometheanbiopharma.com
1300 749 330 (Australia)

Promethean1 transparent.png

© 2023 Promethean BioPharma Ltd

All Rights Reserved

bottom of page